Neurocrine Bioscience buy Piper Sandler
Start price
31.07.25
/
50%
€115.25
Target price
31.07.26
€153.09
Performance (%)
39.39%
Price
17:35
€160.65
This prediction will end soon
Summary
This prediction is currently active. With a performance of 39.39% the BUY prediction by Piper_Sandler is a big success. This prediction currently runs until 31.07.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.294% | 2.294% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Piper Sandler from $154.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€176.61
06.05.27
06.05.27
30.45%
17:35
17:35
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
36.32%
17:35
17:35
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.90
06.05.25
06.05.25
€136.35
06.05.26
06.05.26
17.00%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-6.36%
24.12.25
24.12.25